Head-to-head · WeighScore
Somira Health vs Tyde Wellness
The verdict
Tyde Wellness takes it — 79.8/100 to 62.5/100.
Tyde Wellness grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Tyde Wellness is a 50-state compounded-GLP-1 and longevity telehealth platform spanning weight loss, HRT, hair, and peptides.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Somira Health | Tyde Wellness |
|---|---|---|
| WeighScore | 62.5/100 | 79.8/100 |
| Grade | C | C+ |
| Scorecard rank | #269 | #39 |
| Semaglutide | $190/mo (compounded) | $149/mo (microdose tier, all doses, compounded) |
| Tirzepatide | $285/mo (compounded) | $249/mo (microdose tier, all doses, compounded) |
| Coverage | Coverage not published | All 50 states |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Yes |
Graded #269 · C
Strengths
- Transparent flat monthly pricing that does not increase as you titrate (semaglutide $189.99/mo, tirzepatide $284.99/mo)
- Quarterly plans lower the effective monthly cost (semaglutide $136.66/mo, tirzepatide $221.66/mo)
- Free overnight shipping, with syringes and alcohol wipes included in every order
- Simple, fast online intake reviewed by a licensed provider; no insurance required
- Both weekly compounded GLP-1 options offered: semaglutide and tirzepatide
Where it loses points
- Compounded medications are not FDA-approved (the site discloses this) — not brand Wegovy, Ozempic, Zepbound, or Mounjaro
- The compounding pharmacy partner is not named
- State-availability list is not published
- No LegitScript certification displayed
- New, thin platform with limited public detail on the provider network, lab monitoring, or ongoing support
Graded #39 · C+
Strengths
- All 50 states served (full list published)
- Transparent pricing: semaglutide from $149/mo, tirzepatide from $249/mo
- LegitScript Certified with a verification link
- Five named 503A pharmacy partners with addresses: Belmar (CO), Casa (TX), Olympia (FL), Red Rock (UT), Beaker (TX)
- Free consultation; cancel-anytime subscription with no long-term commitment
Where it loses points
- Compounded semaglutide and tirzepatide are not FDA-approved finished products
- No brand-name GLP-1s (Wegovy, Zepbound, Mounjaro, Ozempic)
- Tirzepatide priced higher than competitors offering $200-$249/mo
- Corporate address and medical director not publicly disclosed
- No NABP .pharmacy seal visible
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.